Early Safety Findings Among Persons Aged ≥60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024

MMWR Morb Mortal Wkly Rep. 2024 May 30;73(21):489-494. doi: 10.15585/mmwr.mm7321a3.
No abstract available

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Male
  • Middle Aged
  • Respiratory Syncytial Virus Infections* / epidemiology
  • Respiratory Syncytial Virus Infections* / prevention & control
  • Respiratory Syncytial Virus Vaccines* / administration & dosage
  • United States / epidemiology

Substances

  • Respiratory Syncytial Virus Vaccines